INSTYTUT CHEMII BIOORGANICZNEJ PAN

Patent Applications and Registrations

Patent applications and USPTO patent grants for INSTYTUT CHEMII BIOORGANICZNEJ PAN.The latest application filed is for "method for creating a predictive model for predicting glaucoma risk in a subject, method for determining glaucoma risk in a subject using such predictive model, device for predicting glaucoma risk in a subject, computer program and computer readable medium".

Company Profile

4.11.14

INSTYTUT CHEMII BIOORGANICZNEJ PAN - Poznan PL
INSTYTUT CHEMII BIOORGANICZNEJ PAN - Pozna N/A PL
INSTYTUT CHEMII BIOORGANICZNEJ PAN - Posnan PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Creating A Predictive Model For Predicting Glaucoma Risk In A Subject, Method For Determining Glaucoma Risk In A Subject Using Such Predictive Model, Device For Predicting Glaucoma Risk In A Subject, Computer Program And Computer Readable Medium App 20210319903 - WASILEWICZ; Robert Henryk ; et al.	2021-10-14
Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats Grant 10,329,566 - Krzyzosiak , et al.	2019-06-25
Nucleic Acid Molecule, Expression Cassette, Expression Vector, Eukaryotic Host Cell, Induction Method Of Rna Interference In Eukaryotic Host And Use Of The Nucleic Acid Molecule In Therapy Of Diseases Induced By Expansion Of Trinucleotide Cag Repeats App 20190024081 - KRZYZOSIAK; Wlodzimierz ; et al.	2019-01-24
Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interferencde in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats Grant 9,970,004 - Krzyzosiak , et al. May 15, 2	2018-05-15
Lyme disease vaccine, genetic construct, recombinant protein, method for designing genetic construct, method for producing vaccine, method for producing recombinant proteins, use of recombinant proteins in the production of lyme disease vaccine Grant 9,562,080 - Urbanowicz , et al. February 7, 2	2017-02-07
Nucleic Acid Molecule, Expression Cassette, Expression Vector, Eukaryotic Host Cell, Induction Method Of Rna Interferencde In Eukaryotic Host And Use Of The Nucleic Acid Molecule In Therapy Of Diseases Induced By Expansion Of Trinucleotide Gag Repeats App 20160376586 - KRZYZOSIAK; Wlodzimierz ; et al.	2016-12-29
Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition Grant 9,206,209 - Kraszewski , et al. December 8, 2	2015-12-08
Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylation Grant 9,040,490 - Barciszewski , et al. May 26, 2	2015-05-26
Lyme disease vaccine, genetic construct, recombinant protein, method for designing genetic construct, method for producing vaccine, method for producing recombinant proteins, use of recombinant proteins in the production of Lyme disease vaccine App 20150093408 - Urbanowicz; Anna ; et al.	2015-04-02
Modified Gene Of Human Activation-induced Cytidine Deaminase (aid), A Method Of Modification Of Human Aid Gene, A Composition Showing Aid Activity, A Method Of Preparation Of Such Composition In A Bacterial System And Use Of The Composition In The Analyses Of Dna/rna Amination/deamination And/or Met App 20150044675 - Budzko; Lucyna ; et al.	2015-02-12
Sequence of dsRNA: ATN-RNA specific for tenascin-C Grant 8,946,400 - Barciszewski , et al. February 3, 2	2015-02-03
Peptide With The Enzymatic Activity Of A Dicer-like Protein, A Method For Preparing Short Rna Molecules, And Use Thereof App 20140186895 - Figlerowicz; Marek ; et al.	2014-07-03
Method of obtaining of 4-N-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-N-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition Grant 8,404,660 - Barciszewski , et al. March 26, 2	2013-03-26
Combinatorial Library, A Method For Preparation Of That Combinatorial Library, A Method For Sequence Identification, A Method For Sequencing The Elements Of Combinatorial Libraries Of Oligonucleotides And/or Oligonucleotide Analogues, The Use Of A Linker To Generate Combinatorial Libraries And A Seq App 20130053258 - Markiewicz; Wojciech T. ; et al.	2013-02-28
Cytosine Analogue, A Method Of Preparation Of A Cytosine Analogue, A Dna Methyltransferase 1 Inhibitor, A Method For Dna Methylation Inhibition, The Use Of The Analogue In The Treatment Of Diseases Associated With Deviations From Normal Dna Methylation App 20120322755 - Barciszewski; Jan ; et al.	2012-12-20
Method To Inhibit Ribonuclease Dicer, Ribonuclease Dicer Inhibitor, And Use Of Rna Aptamers As Ribonuclease Dicer Inhibitors App 20110207197 - Figlerowicz; Marek ; et al.	2011-08-25
Method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and anti-aging composition Grant 7,923,578 - Barciszewski , et al. April 12, 2	2011-04-12
Computer-based Modeling And Designing Of Phosphofructokinase 1 (pfk) Modulators App 20110060574 - Rypniewski; Wojciech ; et al.	2011-03-10
Method Of Obtaining Of 4-n-furfurylcytosine And/or Its Derivatives, An Anti-aging Composition And Use Of 4-n-furfurylcytosine And/or Its Derivatives In The Manufacture Of Anti-aging Composition App 20100317612 - Barciszewski; Jan ; et al.	2010-12-16
Crystallographic Model Of The Binding Site And A Modulator Regulating The Catalytic Activity Of Phosphofructokinase (pfk), A Method Of Designing, Selecting And Producing The Pfk Modulator, A Computer-based Method For The Analysis Of The Interactions Between The Modulator And Pfk App 20100286429 - Rypniewski; Wojciech ; et al.	2010-11-11
Sequence Of Dsrna: Atn-rna, Intervention Using Irnai, Use Of A Sequence Of Dsrna: Atn-rna, A Method Of Treating And Inhibiting A Brain Tumor, A Kit For Inhibiting Cancer Cell Which Expresses Tenascin, A Method For A Kit Preparation In A Brain Tumor Therapy App 20100076053 - Barciszewski; Jan ; et al.	2010-03-25
Method of Manufacturing 3-(4-Hydroxyphenyl)Propanoic Acid Amide, Its Application in the Manufacture of Anti-Aging Compositions and Anti-Aging Composition App 20080249334 - Barciszewski; Jan ; et al.	2008-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.